Clean, humanized data and data systems are the crucial fuel for engines driving new AI capabilities and uses across the ...
Incremental Opportunities: The industry is set to create an incremental opportunity of USD 20.1 billion, rising 1.7 times its ...
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
“Time-to-market is money,” says Lukas Kürten, Digital Innovation Manager at CPI. “If you’ve got a process that works, you’ve got to throw it into manufacturing, because you’ve got to milk your patent ...
Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and ...
Precision BioSciences (DTIL) stock saw a 31% premarket surge after positive results from its gene therapy trial for treating ...
A consortium of 14 pharmaceutical companies will now use those samples and start the largest proteomics study to date.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback